Dr. Alqurashi is an Associate Professor at the University of Ottawa and a Scientist at the CHEO Research Institute. He completed his pediatric residency at the Montreal Children’s Hospital, followed by a fellowship in pediatric emergency medicine at CHEO. Dr. Alqurashi obtained a master’s degree in clinical epidemiology from the University of Ottawa and a research fellowship from the Society for Academic Emergency Medicine. Recently, he completed post-graduate degree in allergy at Imperial College London, UK.
Since joining CHEO’s Division of Emergency Medicine, he has focused his research on allergy and anaphylaxis. His work in this area has been supported by federal and provincial grants. He serves as the emergency department (ED) lead for CHEO’s Antimicrobial Stewardship Program. He is an anaphylaxis content advisor and editorial committee member for the TREKK network.
Related News
Research Projects
-
Cephalexin use in a pediatric emergency Department during the shortage of amoxicillin suspension
12/11/2025
During a significant shortage of amoxicillin suspension in Canada in late 2022, local guidelines recommended cephalexin as an alternative with restricted use of amoxicillin-clavulanate (AC). The aim of the study was to determine outcomes of patients with a diagnosis of acute otitis media (AOM), community acquired pneumonia (AOM) and pharyngitis who were prescribed cephalexin compared to other antibiotics in the emergency department (ED).
-
Epinephrine MDI for Pediatric Croup. Academic Emergency Medicine
24/10/2022
The QA network formed a committee of Canadian experts in pediatric emergency medicine, pharmacology, critical care, and aerosol delivery who, through consensus, approved an assessment and dosing algorithm that incorporated relevant evidence identified through literature review. Using a standardized bedside data collection form, the algorithm recommended administering five puffs (125 μg/puff) via MDI with a valved holding chamber (VHC), with assessment recommended 10 min later for clinical improvement using the Westley Croup Score (WCS)4 and for adverse effects by documenting heart rate (HR), cardiac rhythm, and presence of tremor or agitation.
-
Canadian Anaphylaxis Network- Predicting Recurrence after Emergency Presentation for Allergic REaction (CAN-PREPARE): A Prospective, Cohort Study Protocol
09/10/2022
-
Separating Fact from Fiction in the Diagnosis and Management of Food Allergy
19/10/2021
The goal of this commentary is to review important themes that have emerged in our understanding of food allergy management.
-
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-analysis, GRADE Assessment, and International Consensus Approach.
18/06/2021
We recommend further research to clarify SARS-CoV-2 vaccine/vaccine excipient testing utility in individuals potentially allergic to SARS-CoV2 vaccines or their excipients.